Comments
Loading...

Altamira Therapeutics

CYTONASDAQ
Logo brought to you by Benzinga Data
$0.720100
-0.03-3.99%
Last update: 8:46 AM
15 minutes delayed
H1 2024 Earnings in 4 days from now on Tue Sep 24th, before the market open

Altamira Therapeutics (NASDAQ:CYTO) Stock, Earnings Estimates, EPS, And Revenue

Altamira Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Apr 10
EPS
$-16.470
Quarterly Revenue
$284.5K
Annual Revenue
(as of Dec 31)

Analyze the earnings history of Altamira Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Altamira Therapeutics (CYTO) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %

Altamira Therapeutics (CYTO) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Altamira Therapeutics (NASDAQ:CYTO) reporting earnings?

A

Altamira Therapeutics (CYTO) is scheduled to report earnings on September 24, 2024. The last reported earnings were for reported on April 10, 2024 for FY.

Q

What were the latest earnings per share (EPS) for Altamira Therapeutics (NASDAQ:CYTO)?

A

The Actual EPS was $-16.47, which missed the estimate of $0.00.

Q

What were Altamira Therapeutics’s (NASDAQ:CYTO) revenues?

A

The Actual Revenue was $284.5K, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch